About Metoprolol Succinate API
Therapeutic Category Cardiovascular

CAS Number
98418-47-4
API Technology
Synthetic
Dose Form
Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, Canada DMF, China DMF
Mechanism of Action
Several possible mechanisms have been proposed:
- Competitive antagonism of catecholamine at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output;
- A central effect leading to reduced sympathetic outflow to the periphery; and
- Suppression of renin activity.
Indication
- Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
- Angina Pectoris.
- Heart Failure - for the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or cardiomyopathic origin.
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
FAQs
What are the uses of Metoprolol Succinate API?
Treats hypertension (high blood pressure)
Manages angina (chest pain)
Reduces risk of heart failure hospitalization
What are the precautions to take while using Metoprolol Succinate?
Avoid abrupt discontinuation
Inform doctor of any respiratory issues, diabetes, or liver disease
Avoid driving until you know its effects
What are the benefits of metoprolol Succinate API?
Lowers blood pressure
Reduces chest pain frequency
Improves survival rates in heart failure patients